Cargando…

Implementing a national cancer clinical trials system for the 21st century : second workshop summary : an American Society of Clinical Oncology and Institute of Medicine Workshop /

"The National Clinical Trials Network (NCTN) supported by the National Cancer Institute (NCI) has played an integral role in cancer research and in establishing the standard of care for cancer patients for more than 50 years. Formerly known as the NCI Clinical Trials Cooperative Group Program,...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Nass, Sharyl J. (Autor), Patlak, Margie (Autor)
Autores Corporativos: American Society of Clinical Oncology (sponsoring body.), National Cancer Policy Forum (U.S.) (sponsoring body.), Institute of Medicine (U.S.). Board on Health Care Services (sponsoring body.), American Society of Clinical Oncology and Institute of Medicine Workshop
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, [2013]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn893439605
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 141020s2013 dcuab ob 100 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d COO  |d YDXCP  |d EBLCP  |d OCLCQ  |d OCLCO  |d OCLCQ  |d D6H  |d OCLCQ  |d OCLCO  |d ZCU  |d OCLCO  |d MERUC  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCF  |d VTS  |d ICG  |d OCLCQ  |d OCLCO  |d OCLCA  |d DKC  |d OCLCQ  |d AJS  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL 
019 |a 863088077  |a 923289843  |a 1028807322  |a 1204385775 
020 |a 9780309287258  |q (electronic bk.) 
020 |a 0309287251  |q (electronic bk.) 
020 |z 9780309287241 
020 |z 0309287243 
029 1 |a AU@  |b 000054147079 
029 1 |a DEBBG  |b BV042795686 
029 1 |a DEBBG  |b BV044185096 
029 1 |a DEBSZ  |b 424585804 
035 |a (OCoLC)893439605  |z (OCoLC)863088077  |z (OCoLC)923289843  |z (OCoLC)1028807322  |z (OCoLC)1204385775 
043 |a n-us--- 
050 4 |a RC270.8  |b .I45 2013eb 
060 4 |a 2014 A-970 
060 4 |a QZ 266 
072 7 |a POL  |x 027000  |2 bisacsh 
072 7 |a POL  |x 019000  |2 bisacsh 
082 0 4 |a 362.19699/4  |2 23 
049 |a UAMI 
100 1 |a Nass, Sharyl J.,  |e author. 
245 1 0 |a Implementing a national cancer clinical trials system for the 21st century :  |b second workshop summary : an American Society of Clinical Oncology and Institute of Medicine Workshop /  |c Sharyl J. Nass and Nargie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. 
264 1 |a Washington, D.C. :  |b National Academies Press,  |c [2013] 
300 |a 1 online resource (xvii, 92 pages) :  |b illustrations, map 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
520 |a "The National Clinical Trials Network (NCTN) supported by the National Cancer Institute (NCI) has played an integral role in cancer research and in establishing the standard of care for cancer patients for more than 50 years. Formerly known as the NCI Clinical Trials Cooperative Group Program, the NCTN is comprised of more than 2,100 institutions and 14,000 investigators, who enroll more than 20,000 cancer patients in clinical trials each year across the United States and internationally. Recognizing the recent transformative advances in cancer research that necessitate modernization in how cancer clinical trials are run, as well as inefficiencies and other challenges impeding the national cancer clinical trials program, the NCI asked the IOM to develop a set of recommendations to improve the federally funded cancer clinical trials system. These recommendations were published in the 2010 report, A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. In early 2011, the NCPF and the American Society of Clinical Oncology (ASCO) held a workshop in which stakeholders discussed the changes they planned to implement in response to the IOM goals and recommendations. Two years later, on February 11-12, 2013, in Washington, DC, the NCPF and ASCO reconvened stakeholders to report on the changes they have made thus far to address the IOM recommendations. At this workshop, representatives from the NCI, the NCTN, comprehensive cancer centers, patient advocacy groups, the Food and Drug Administration (FDA), industry, and other stakeholders highlighted the progress that has been made in achieving the goals for a reinvigorated national cancer clinical trials system. Implementing a National Cancer Clinical Trials System for the 21st Century is a summary of that workshop. ."--Publisher's description 
505 0 |a Improving speed and efficiency of trials -- Fostering innovation -- Improving prioritization, selection, support, and completion of trials -- Incentivizing patient and physician participation -- Regulatory issues. 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
610 2 0 |a American Society of Clinical Oncology. 
610 2 7 |a American Society of Clinical Oncology  |2 fast 
650 0 |a Cancer  |x Treatment  |x Government policy  |z United States. 
650 0 |a Clinical trials  |x Standards  |z United States. 
650 0 |a Medical policy. 
650 1 2 |a Neoplasms  |x therapy 
650 2 2 |a Clinical Trials as Topic  |x standards 
650 2 2 |a Health Policy 
650 2 2 |a Patient Care  |x standards 
651 2 |a United States 
650 6 |a Cancer  |x Traitement  |x Politique gouvernementale  |z États-Unis. 
650 6 |a Études cliniques  |x Normes  |z États-Unis. 
650 6 |a Politique sanitaire. 
650 7 |a POLITICAL SCIENCE  |x Public Policy  |x Social Security.  |2 bisacsh 
650 7 |a POLITICAL SCIENCE  |x Public Policy  |x Social Services & Welfare.  |2 bisacsh 
650 7 |a Medical policy  |2 fast 
650 7 |a Clinical trials  |x Standards  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Patlak, Margie,  |e author. 
710 2 |a American Society of Clinical Oncology,  |e sponsoring body. 
710 2 |a National Cancer Policy Forum (U.S.),  |e sponsoring body. 
710 2 |a Institute of Medicine (U.S.).  |b Board on Health Care Services,  |e sponsoring body. 
711 2 |a American Society of Clinical Oncology and Institute of Medicine Workshop  |n (2nd :  |d 2013 :  |c Washington, D.C.) 
758 |i has work:  |a Implementing a national cancer clinical trials system for the 21st century (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGxCcmfxMKrCcxFt6vGXgq  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Nass, Sharyl J.  |t Implementing a national cancer clinical trials system for the 21st century  |z 9780309287241  |w (DLC) 2013370295  |w (OCoLC)863628183 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3379128  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3379128 
938 |a EBSCOhost  |b EBSC  |n 867920 
938 |a YBP Library Services  |b YANK  |n 11864844 
994 |a 92  |b IZTAP